EQV · As filed with the SEC
EQV Ventures Acquisition cash flow statement, by quarter
The statement as EQV Ventures Acquisition presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Cash Flows (Unaudited) · USD
| USD | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net income | (3,036,568)† | 2,725,375† | 3,258,178 | 3,941,985† |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||
| Interest earned on cash held in trust account | — | — | (3,870,125) | 0† |
| Interest earned on investments held in the trust account | (4,029,558)† | — | — | (4,219,371)† |
| Change in fair value of over-allotment liability | — | — | — | 0† |
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | — | — | 35,837 | 12,608† |
| Short term prepaid insurance | (39,161)† | — | — | 0† |
| Long term prepaid insurance | — | — | 29,371 | 29,371† |
| Cash underwriting fees payable | — | — | (52,083) | — |
| Accrued expenses | 5,695,155† | 891,175† | 365,996 | 3,078† |
| Net cash used in operating activities | (1,131,124)† | (283,589)† | (232,826) | (388,579)† |
| Cash Flows from Investing Activities: | ||||
| Investment of cash into the trust account | — | — | — | 0† |
| Cash withdrawn from the trust account for working capital purposes | 402,307† | 397,599† | 391,472 | 434,060† |
| Net cash provided by (used in) investing activities | 402,307† | 397,599† | 391,472 | 434,060† |
| Cash Flows from Financing Activities: | ||||
| Proceeds from sale of Units, net of underwriting discounts paid | — | — | — | 52,083† |
| Proceeds from sale of Private Placement Units | — | — | — | 0† |
| Issuance of Class A shares to non-executive director nominees | — | — | — | 0† |
| Proceeds from promissory note - related party | — | — | — | 0† |
| Repayment of promissory note - related party | — | — | — | 0† |
| Payment of offering costs | 260,417† | (260,417)† | (60,000) | 0† |
| Net cash (used in) provided by financing activities | (156,250)† | (260,417)† | (60,000) | 52,083† |
| Net change in cash and cash equivalents | (885,067)† | (146,407)† | 98,646 | 97,564† |
| Cash and cash equivalents – Beginning of period | 925,722 | 1,072,129 | 973,483 | 875,919 |
| Cash and cash equivalents – End of period | 40,655 | 925,722 | 1,072,129 | 973,483 |
| Noncash investing and financing activities: | ||||
| Offering costs included in accrued offering costs | — | — | — | 0† |
| Deferred underwriting fees payable | — | — | — | 0† |
| Forfeiture of founder shares | — | — | — | 0† |
| Write off of over-allotment liability | — | — | — | 0† |
| Deferred legal fee payable | — | — | — | 746,271† |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.